Are Tradjenta and Onglyza the Same Thing?
Side effects of Onglyza that are different from Tradjenta include stomach pain.
Both Tradjenta and Onglyza may interact with other oral diabetes medications.
Tradjenta may also interact with bosentan, dexamethasone, ketoconazole, quinidine, verapamil, rifabutin, rifampin, rifapentine, St. John's wort, barbiturates, medication to treat HIV/AIDS, medicines to treat narcolepsy, medicines used to prevent organ transplant rejection, seizure medications, probenecid, nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin or other salicylates (including Pepto-Bismol), sulfa drugs, monoamine oxidase inhibitors (MAOIs), and beta-blockers.
Onglyza may also interact with some antibiotics, HIV/AIDS medications, itraconazole, and nefazodone.
What Are Possible Side Effects of Tradjenta?
Common side effects of Tradjenta include:
- stuffy nose,
- runny nose,
- sore throat,
- weight gain,
- muscle or joint pain,
- back pain, or
- low blood sugar.
Tradjenta may cause serious side effects, including:
- inflammation of the pancreas (pancreatitis, symptoms include severe pain in your upper stomach spreading to your back, nausea and vomiting,
- loss of appetite,
- fast heart rate),
- fever, and headache with a severe blistering, peeling, and red skin rash.
What Are Possible Side Effects of Onglyza?
Common side effects of Onglyza include:
- runny or stuffy nose,
- sore throat,
- headache, or
- stomach pain.
Onglyza by itself usually does not cause low blood sugar (hypoglycemia), but low blood sugar may occur if this drug is prescribed with other anti-diabetic medications. Symptoms of low blood sugar include sudden sweating, shaking, fast heartbeat, hunger, blurred vision, dizziness, or tingling hands/feet. Get medical help if you have very serious side effects of Onglyza including:
- signs of disease of the pancreas (such as severe stomach or abdominal pain which may spread to the back, or persistent nausea or vomiting).
What Is Tradjenta?
Tradjenta (linagliptin) tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
What Is Onglyza?
Onglyza (saxagliptin) is an orally-active inhibitor of the DPP4 enzyme used either alone or with other medications, and with a proper diet and exercise program, to control high blood sugar. Onglyza is used in people with type 2 (non-insulin-dependent) diabetes.
What Drugs Interact With Tradjenta?
Tradjenta may interact with bosentan, dexamethasone, ketoconazole, quinidine, verapamil, rifabutin, rifampin, rifapentine, St. John's wort, phenobarbital and other barbiturates, medication to treat HIV or AIDS, medicines to treat narcolepsy, medicines used to prevent organ transplant rejection, seizure medications, probenecid, nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin or other salicylates (including Pepto-Bismol), sulfa drugs, monoamine oxidase inhibitors (MAOIs), beta-blockers, or other oral diabetes medications. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Tradjenta; it is not expected to harm an unborn baby. It is unknown if Tradjenta passes into breast milk or if it could harm a nursing baby. Consult your doctor before breastfeeding.
What Drugs Interact With Onglyza?
Onglyza may interact with tazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, and telithromycin. Low blood sugar may occur if this drug is prescribed with other anti-diabetes medications. During pregnancy, Onglyza should be used only when prescribed. Pregnancy may cause or worsen diabetes. Your doctor may change your diabetes treatment during your pregnancy. It is unknown if this medication passes into breast milk. Consult your doctor before breastfeeding.
How Should Tradjenta Be Taken?
The recommended dose of Tradjenta is 5 mg once daily.
How Should Onglyza Be Taken?
The recommended dose of Onglyza is 2.5 mg or 5 mg once daily taken regardless of meals.
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
Boehringer Ingelheim Pharmaceuticals, Inc. Tradjenta Product Information.
AstraZeneca. Onglyza Product Information.